EMBC Special Issue: SAM-HovNet: SAM-Enhanced Multi-Class Nucleus Segmentation and Classification in Hepatocellular
IEEE Transactions on Bio-Medical Engineering
|August 4, 2026
Summary
Automated analysis of liver cancer cells (Hepatocellular carcinoma - HCC) is improved with SAM-HovNet. This deep learning framework enhances nucleus segmentation and classification, offering a more reliable tool for pathology research.
Area of Science:
- Digital pathology
- Computational oncology
- Artificial intelligence in medicine
Background:
- Hepatocellular carcinoma (HCC) is a prevalent primary liver cancer with high mortality.
- Manual analysis of HCC nuclei in histopathology is time-consuming and inconsistent.
- Current deep learning models struggle with accurate nucleus segmentation and classification in liver tissue.
Purpose of the Study:
- To develop an advanced deep learning framework, SAM-HovNet, for precise multi-class nucleus segmentation and classification in HCC histopathology.
- To improve upon existing methods by integrating the SAM foundation model, Squeeze-and-Excitation modules, and multi-scale features.
Main Methods:
- Proposed SAM-HovNet, a unified framework enhancing HoverNet with SAM, Squeeze-and-Excitation modules, and multi-scale features.
- Utilized the HCCNuc dataset for training and evaluation.
- Validated generalizability on the public PanNuke dataset.
Main Results:
- SAM-HovNet achieved an image-level mean F1-score of 0.577 and a mean panoptic quality (PQ) of 0.521 on the HCCNuc dataset.
- Demonstrated superior performance and generalizability compared to existing methods on the PanNuke dataset.
Conclusions:
- SAM-HovNet offers a robust and accurate solution for automated nucleus segmentation and classification in HCC.
- The framework shows significant potential for advancing downstream nuclear characterization in liver cancer pathology.
More Related Videos
11:00Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
Published on: March 25, 2020
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
